Dose-dependent oral glucocorticoid cardiovascular risk in people with immune-mediated inflammatory diseases (2020)
Attributed to:
MICA: Treatment According to Response in Giant cEll arTeritis (TARGET)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.03.11.20034157
Publication URI: http://dx.doi.org/10.1101/2020.03.11.20034157
Type: Preprint